Thanks for signing up for DividendStocks.com! It's the daily newsletter built for dividend and income investors. Before we can begin sending your daily updates, there’s one quick step left. Please confirm your subscription using the link below so our emails reach your inbox. Click Here to Confirm Your Subscription to DividendStocks.com Here’s a small glimpse of what you’ll get access to: Dividend Stock Ideas — Each newsletter features dividend stocks with high yields, sustainable payouts, and strong growth potential. Ex-Dividend Stocks — Want to capture upcoming dividend payouts? Find out which stocks are going ex-dividend this week. Market News and Events — Stay in the loop on the latest developments impacting popular dividend names like AT&T, Exxon Mobil, IBM, Procter & Gamble, and Verizon. Bonus: As a thank-you for confirming, you’ll also receive a free PDF copy of Automatic Income, our popular guide to building wealth through dividend investing. Let’s get your dividend journey started! Discover Top Income-Generating Stocks Here See you in your inbox soon,
The DividendStocks.com Team P.S. Don’t miss out click here to verify your subscription and secure your daily dividend insights and your free investing guide!
Today's Bonus Content 3 Blue-Chip Stocks Built for a Rotating MarketWritten by Chris Markoch. Posted: 3/8/2026. 
Key Points - Sector rotation in 2026 is favoring defensive, value-oriented areas such as utilities, healthcare, and consumer staples over mega-cap technology.
- Duke Energy and Gilead Sciences combine defensive characteristics with identifiable growth catalysts and reliable dividends.
- Hershey has rallied sharply with consumer staples, but its valuation now looks stretched relative to its earnings profile.
- Special Report: Elon Musk: This Could Turn $100 into $100,000
Sector rotation occurs when investors move money out of sectors that look overbought and into ones that appear undervalued. In 2026, that has generally meant rotating away from mega-cap technology names and into value stocks, especially defensive sectors such as energy and consumer staples. The key issue is overvaluation. Big tech has been hot for more than two years, driven largely by excitement around artificial intelligence (AI). Despite concerns about a dot-com–style repeat, investors largely ignored lofty valuations for many of those names. But valuation often matters when sentiment shifts. As the economy begins to heat up, investors are searching for value elsewhere, including blue-chip defensive names like the stocks highlighted below. Utilities Provide Stability in a Rotating Market Duke Energy (NYSE: DUK) is a logical beneficiary of sector rotation. Duke is a well-known utility provider in the Southeast and Midwest United States. Utility stocks are among the most defensive, typically considered value and income plays. Duke offers an attractive, secure dividend that yields about 3.2%, and the company has raised its payout for 20 consecutive years. The evolving U.S. energy landscape also creates growth opportunities for DUK. The company follows an "all of the above" strategy that includes nuclear, hydroelectric and natural gas generation. Stronger natural gas fundamentals helped lift the stock in 2026, but Duke's steady revenue from its residential utility business and projected growth from areas such as data centers are what make DUK an attractive sector-rotation target. DUK is up nearly 12% in 2026, placing it within about 5% of the consensus price target of $136.87, which would push the stock above its 52-week high. Trading at roughly 20.5x earnings, the stock sits at a slight premium to its historical average. Since Duke's February earnings report, analysts have been raising price targets amid expectations for strong year-over-year revenue growth in the back half of the year, a dynamic that could prompt a bullish re-rating. Biotech Strength Gives Gilead Defensive Growth Some analysts expect biotechnology names to benefit from the current rotation. Gilead Sciences (NASDAQ: GILD) offers defensive growth within healthcare, a sector that has largely lagged the broader market. Gilead is a leading provider of HIV therapies, with key drugs protected by patents into the 2030s. Investors are also upbeat about a pipeline of more than 50 candidates. Beyond HIV, Gilead expects to launch anito-cel, a CAR-T therapy for multiple myeloma, in 2026, and the company may also see a label expansion for its breast cancer drug, Trodelvy. GILD is up nearly 18% in 2026 and reached a 52-week high during that run. It has pulled back slightly since then, which appears to be profit-taking after an outsized move and could create a buy-the-dip opportunity. Analysts have a consensus price target of $156.72 on GILD, implying more than an 8% upside. Many analysts have raised targets since the February earnings report, with the most bullish calls near $170. Gilead also pays a reliable dividend, yielding about 2.28%, and the company has increased its dividend for 10 consecutive years. Consumer Staples Rally Lifts Hershey Stock The Hershey Company (NYSE: HSY) has been a major beneficiary of the rotation into consumer staples in 2026. HSY is up nearly 25% this year and has broken out of the bearish trend that began in 2023. Hershey grappled with higher cocoa costs through 2025, an issue that will still pressure earnings in 2026. However, the market looks forward, and analysts are forecasting stronger earnings and revenue growth this year. HSY is trading above its consensus price target of $222.21, and analysts have been raising targets since the February earnings report. Goldman Sachs' most bullish call sits at $267. In that report, Hershey increased its dividend by 5.9%, marking 15 consecutive years of dividend hikes for the company, which yields roughly 2.5% and pays $5.81 per share annually. After the recent rally, HSY trades at over 50x earnings — a valuation that likely prompted heavy institutional selling last quarter. For prospective investors, that pullback could offer a second chance to buy into this well-known consumer franchise. | 
